FDA/CDRH Interim Response to Carmel Pharma, Inc. - Letter

This Other document was issued by the Food and Drug Administration (FDA)

For related information, Open Docket Folder  Docket folder icon


Content

See attached file(s)

Attachments

 (1)

FDA/CDRH Interim Response to Carmel Pharma, Inc. - Letter

View Attachment:

 
 
ID: FDA-2008-P-0196-0007

Document Information

Date Posted: Sep 22, 2008
Show More Details  

Comments

2
Comments Received*
Dear Madam or Sir Please find attached our response to Carmel Pharma amendment posted on January 26, 2009. Sincerely Yossi Shachar QA/RA Manager Teva Medical...
Dear Madam or Sir Please find attached our response to Carmel Pharma amendment posted on January 26, 2009. Sincerely Yossi Shachar AQ/RA Manager Teva Medical...

Docket Information

This document is contained in
Related Comments:

* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.